ARGX-121: Safety Study in Healthy Adults
We are assessing the safety of the new treatment ARGX-121 in healthy adult participants. This study aims to ensure the treatment is safe for future use.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Pharmaceutical Research Associates Group B.V.
Program Management
Groningen, Netherlands
Sponsor: Argenx
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.